cinclus pharma header news

Media

Media

Press releases and topics in the spotlight

Welcome to our media section. Check out the latest interviews, news, and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information. 

Media gallery

Latest pressreleases


See allSubscribe

In the spotlight


Cinclus Arvet Fran Astra

We develop the future GERD treatment which has roots in AstraZeneca

Highlights from the 2024 Annual Report: Interview with the founders. Cinclus Pharma, founded by a team of experts with deep roots in the pharmaceutical industry, is on a mission to bring an effective GERD treatment, linaprazan glurate, to the market…

Cinclus News Image Prateek

A Doctor’s perspective on linaprazan glurate’s unique potential

Highlights from the 2024 Annual Report: Interview with Dr. Prateek Sharma. Dr. Prateek Sharma, Medical Advisor and expert in gastrointestinal diseases and cancer, shares his insights on its safety and potential usage areas.

Cinclus News Image Nina

Nina Rawal, Trill Impact Ventures, on the investment in Cinclus Pharma

Highlights from the 2024 Annual Report: Interview with Nina Rawal. Trill Impact Ventures views Cinclus Pharma as a strong Life Science candidate with the potential to address unmet medical needs in GERD and H. pylori. Nina Rawal, Co-Head of Ventures…

Cinclus News Image Kajsa

Kajsa Larsson, CMO, on the upcoming Phase III studies of linaprazan glurate

Highlights from the 2024 Annual Report: Interview with Kajsa Larsson. The study will involve around 500 patients from eight countries in Europe and North America, with up to 100 hospitals and clinics.